Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
    • Politique du MFC en matière d'IA
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
    • Politique du MFC en matière d'IA
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Case ReportCase Report

Cushing syndrome presenting as persistent delirium

Hana Yu, Paula Horsley, Sarah Wong and Sola Mansour
Canadian Family Physician November/December 2025; 71 (11-12) 719-721; DOI: https://doi.org/10.46747/cfp.711112719
Hana Yu
Assistant Clinical Professor in the Department of Family Medicine, at the University of Alberta in Edmonton.
MD MSc CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hyu1{at}ualberta.ca
Paula Horsley
Assistant Professor in the Department of Medicine, at the University of Alberta in Edmonton.
MD FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Wong
Assistant Clinical Professor in the Department of Psychiatry, at the University of Alberta in Edmonton.
MD FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sola Mansour
Assistant Clinical Professor in the Department of Medicine, at the University of Alberta in Edmonton.
MD MSc FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Delirium is a common condition associated with patient morbidity and mortality.1 Exogenous steroids and pituitary or adrenal dysfunction can cause hypercortisolism (which can lead to Cushing syndrome), and are potential triggers for delirium.2,3 Family physicians are often the first point of contact for patients; therefore, recognizing the diverse physical, cognitive, and psychiatric signs and symptoms of hypercortisolism is important to prevent diagnostic and treatment delays.

Case

An 81-year-old female patient was admitted to hospital with a 1-month history of cognitive and functional decline, bizarre behaviour, hyperglycemia, worsening leg edema, and elbow cellulitis that was being treated with an antibiotic. Her medical history was notable for myelodysplastic syndrome, immunoglobulin G4-related disease, diabetes mellitus, hypertension, dyslipidemia, leg edema, and osteoporosis. Initial blood work was significant for leukocytosis (25.8×109/L; normal range 4 to 11×109/L), hypokalemia (2.7 mmol/L; normal range 3.5 to 5 mmol/L), hyperglycemia (21.8 mmol/L; normal range 3.3 to 11 mmol/L), and elevated hemoglobin A1c test result (12.9% average blood sugar level over the past 2 to 3 months; normal range 4.3% to 5.9%). C-reactive protein, calcium, renal function, and brain natriuretic peptide levels, and other test results for infection were unremarkable.

The patient’s family reported mild cognitive decline over the past year; however, the patient was functionally independent, aside from driving (self-terminated) and administering insulin doses. A month before hospital admission, the patient experienced acute cognitive decline, exhibiting bizarre behaviour (unable to pack for a trip, slowed responses, ordering 2 entrees at a restaurant, day-night reversal). While hospitalized, her cognition and behaviour deteriorated and were in keeping with delirium. The patient began singing, praying, chanting repeatedly, and resisting care. She was overinclusive and experienced fluctuations in mood and alertness. Blood test results for thyroid issues, vitamin B12 level, human immunodeficiency virus, and syphilis were unremarkable. Neuroimaging revealed findings of mild microangiopathic changes. The patient’s symptoms initially responded to risperidone, but the medication was discontinued due to somnolence. The suspected underlying causes of the patient’s delirium, including elbow cellulitis, hyperglycemia, constipation, and cystitis (developed during hospital admission), were treated and her delirium improved, but did not resolve.

The patient’s hospital stay was further complicated when she developed a bleeding gastric ulcer. Due to worsening abdominal pain, a computed tomography scan of her abdomen was performed. It revealed a 6.6 cm by 4.9 cm by 7.5 cm heterogeneous mass arising from the right adrenal gland.

Hormonal evaluation revealed suppressed adrenocorticotropic (ACTH) hormone level (1.1 pmol/L; normal range 1.6 to 13.9 pmol/L), and elevated morning blood cortisol level (867 nmol/L; normal range 120 to 620 nmol/L), testosterone level (6.1 nmol/L; normal <2 nmol/L), 24-hour urine cortisol level (2664 nmol/day; normal <160 nmol/day), and late-night salivary cortisol level (27.4 nmol/L; normal <2.8 nmol/L). Dehydroepiandrosterone sulfate level was high normal (4.0 μmol/L; normal range 0.3 to 4.2 μmol/L). Serum metanephrine and normetanephrine levels were normal. These findings, along with a positron emission tomography scan that showed an intensely hypermetabolic right adrenal mass, supported a diagnosis of adrenal cortical carcinoma causing severe Cushing syndrome.

Given the patient’s comorbidities and the size of the adrenal lesion, the patient was not a candidate for surgical removal. Therefore, the patient was treated medically with ketoconazole to normalize her urinary cortisol level; her 24-hour urine cortisol level subsequently decreased from 2664 nmol/day to 427 nmol/day. She was also concurrently treated for leg cellulitis that developed during her hospital stay; however, it was believed the leg cellulitis was unrelated to her prolonged delirium. As the patient’s cortisol level decreased, her acute medical issues stabilized, including leukocytosis, edema, hypokalemia, abdominal pain, bleeding in the gastrointestinal tract, and diabetes. The patient’s cognition and behaviour also improved substantially, although she did not recover to her previous baseline.

Discussion

Cushing syndrome refers to the constellation of signs and symptoms that result from chronic hypercortisolism, regardless of the underlying cause.3 The most common cause of hypercortisolism is exogenous glucocorticoid therapy; endogenous cortisol overproduction is much less frequent.3 Endogenous Cushing syndrome is categorized as either ACTH-dependent (approximately 80% of cases) or ACTH-independent (approximately 20% of cases).3,4 ACTH-dependent causes include Cushing disease (pituitary adenoma secreting ACTH) and, less commonly, ectopic ACTH secretion from non-pituitary tumours or ectopic corticotropin-releasing hormone secreting tumours.3,4 ACTH-independent causes most often involve adrenal adenomas; other rare causes include adrenal carcinomas, macronodular adrenal hyperplasia, and primary pigmented nodular adrenocortical disease.4

Patients with Cushing syndrome usually present with clinical features of varying severity including obesity, facial plethora, dorsocervical fat pad, ecchymoses, red and purple striae (stretch marks) greater than 1 cm in width, thin skin, poor skin healing, abdominal pain, proximal muscle weakness, hirsutism, lethargy, and edema.3,5 Coexisting conditions may include hypertension, abnormal glucose tolerance, hypokalemia, reduced bone density, dyslipidemia, and infections.3,5,6 Given many of these signs and symptoms are present in other, more common diseases, diagnosis of Cushing syndrome is often delayed.7 Signs and symptoms potentially related to Cushing syndrome in the patient in the above-described case included thin skin, abdominal pain, osteoporosis, and infections, as well as hypokalemia, hyperglycemia, and worsening edema that were resistant to standard therapy.

Cognitive or psychiatric changes that may present with Cushing syndrome are varied and can include depression, irritability, cognitive or memory deficits, changes to personality, anxiety, labile emotions, hyperphagia, hypersomnia or insomnia, posttraumatic stress disorder, and vivid dreams.3-5,8,9 Mania and psychosis are also possible, but rare.8 The hippocampus, amygdala, and frontal cortex of the brain were found to be particularly affected by glucocorticoid excess6 and therefore patients often present with multidomain cognitive deficits.4 The patient in the case above presented with cognitive changes, labile emotions, hyperphagia, and symptoms consistent with mania. Katragadda and colleagues found that a higher level of serum cortisol and longer duration of uncontrolled Cushing syndrome were associated with greater cognitive impairment.10 Therefore, timely diagnosis and treatment of Cushing syndrome is important to maximize a patient’s chance of cognitive recovery.

Initial diagnostic investigation of Cushing syndrome involves confirming hypercortisolism and establishing the underlying cause.3 Screening tests for hypercortisolism include 24-hour urinary free cortisol, late-night salivary cortisol, and 1-mg overnight dexamethasone suppression tests.3 Ideally, 2 or more of these tests should be done to diagnose hypercortisolism.3 Once hypercortisolism is confirmed, a plasma ACTH test is required to help distinguish between ACTH-dependent and ACTH-independent causes.3 Further localization requires additional imaging, such as magnetic resonance imaging of the pituitary gland or computed tomography of the adrenal gland.3

Treatment of endogenous Cushing syndrome aims to address the underlying cause of glucocorticoid excess, usually by surgically removing a tumour.3,6 In cases where surgery is not feasible or fails to achieve remission, medical therapy can be used.6 Options include steroidogenesis inhibitors, glucocorticoid receptor antagonists, and drugs targeting ACTH production.3 Radiation therapy may also be needed in some cases.3 Long-term follow-up is essential, as patients are at risk for adrenal insufficiency requiring glucocorticoid replacement and disease recurrence.3 The patient in the above case was not a candidate for surgery and was therefore treated with a steroidogenesis inhibitor (ketoconazole).

Reflecting on the case of the patient described above, we found her psychiatric and cognitive symptoms to be the most prominent and interesting. Her initial presentation was felt to be most in keeping with delirium secondary to uncontrolled diabetes, cellulitis, constipation, and urinary tract infection. After treating these conditions, the patient improved but not as quickly, or as much as expected, suggesting another contributing etiology. This additional etiology was found inadvertently when a computed tomography scan of the patient’s abdomen was ordered due to pain and ultimately revealed an adrenal mass.

Conclusion

It is challenging to make a diagnosis of Cushing syndrome given its varied presentation and the fact many signs and symptoms are also present in other conditions.7 While screening for Cushing syndrome should not be part of routine delirium investigation given its rarity, it should be considered if delirium is persistent and not responding to treatment as expected, especially if other features of hypercortisolism are present.

Notes

Editor’s key points

  • ▸ Cushing syndrome results from chronic glucocorticoid excess that manifests as physical, cognitive, and psychiatric signs and symptoms.

  • ▸ Consider screening for Cushing syndrome in patients with persistent delirium and clinical features of hypercortisolism.

  • ▸ Endogenous causes of Cushing syndrome are rare; adrenocorticotropic hormone (ACTH)-independent causes most often involve adrenal adenomas.

  • ▸ Consider pharmacotherapy such as steroidogenesis inhibitors, glucocorticoid receptor antagonists or medications targeting ACTH production, or radiation therapy when surgical removal of a tumour is not possible.

Points de repère du rédacteur

  • ▸ Le syndrome de Cushing résulte d’un excès chronique de glucocorticoïdes qui se manifeste par des symptômes physiques, cognitifs et psychiatriques.

  • ▸ Envisagez un dépistage du syndrome de Cushing chez les patients souffrant d’un delirium persistent et ayant les caractéristiques cliniques d’un hypercortisolisme.

  • ▸ Les causes endogènes du syndrome de Cushing sont rares; les causes indépendantes de l’adrénocorticotrophine (ACTH) impliquent le plus souvent des adénomes surrénaliens.

  • ▸ Envisagez une pharmacothérapie comme des inhibiteurs de la stéroïdogenèse, des antagonistes du récepteur des glucocorticoïdes, des médicaments ciblant la production de l’ACTH ou encore une radiothérapie si l’ablation chirurgicale d’une tumeur n’est pas possible.

Footnotes

  • Competing interests

    None declared

  • This article has been peer reviewed.

  • Copyright © 2025 the College of Family Physicians of Canada

References

  1. 1.↵
    1. Witlox J,
    2. Eurelings LS,
    3. de Jonghe JF,
    4. Kalisvaart KJ, et al.
    Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010 Jul 28;304(4):443-51. doi: 10.1001/jama.2010.1013.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Goldhar S,
    2. Frank C.
    Optimizing delirium assessment, management, and prevention: DIMS-PLUS5 framework. Can Fam Physician. 2022 Dec;68(12):897-8. doi: 10.46747/cfp.6812897.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Nieman LK,
    2. Castinetti F,
    3. Newell-Price J,
    4. Valassi E, et al.
    Cushing syndrome. Nat Rev Dis Primers. 2025 Jan 23;11(1):4. doi: 10.1038/s41572-024-00588-w.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Maness DL,
    2. Studebaker G,
    3. Knight CM.
    Cushing’s Syndrome: Rapid Evidence Review. Am Fam Physician. 2024 Sep;110(3):270-80.
    OpenUrlPubMed
  5. 5.↵
    1. Nieman LK,
    2. Biller BM,
    3. Findling JW,
    4. Newell-Price J, et al.
    The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008 May;93(5):1526-40. doi: 10.1210/jc.2008-0125. Epub 2008 Mar 11.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Nieman LK,
    2. Biller BM,
    3. Findling JW,
    4. Murad MH, et al.
    Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Rubinstein G,
    2. Osswald A,
    3. Hoster E,
    4. Losa M, et al.
    Time to Diagnosis in Cushing’s Syndrome: A Meta-Analysis Based on 5367 Patients. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz136. doi: 10.1210/clinem/dgz136.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Santos A,
    2. Webb SM,
    3. Resmini E.
    Psychological complications of Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes. 2021 Jun 1;28(3):325-9. doi: 10.1097/MED.0000000000000633.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Wolkowitz OM,
    2. Burke H,
    3. Epel ES,
    4. Reus VI.
    Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci. 2009 Oct;1179:19-40. doi: 10.1111/j.1749-6632.2009.04980.x.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Katragadda A,
    2. Kunadia J,
    3. Kirsch P,
    4. Dorcely B, et al.
    Cognitive decline in Cushing’s syndrome: A systematic review. J Neuroendocrinol. 2025 Jan;37(1):e13466. doi: 10.1111/jne.13466. Epub 2024 Nov 6.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 71 (11-12)
Canadian Family Physician
Vol. 71, Issue 11-12
November/December 2025
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cushing syndrome presenting as persistent delirium
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cushing syndrome presenting as persistent delirium
Hana Yu, Paula Horsley, Sarah Wong, Sola Mansour
Canadian Family Physician Nov 2025, 71 (11-12) 719-721; DOI: 10.46747/cfp.711112719

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Cushing syndrome presenting as persistent delirium
Hana Yu, Paula Horsley, Sarah Wong, Sola Mansour
Canadian Family Physician Nov 2025, 71 (11-12) 719-721; DOI: 10.46747/cfp.711112719
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Case
    • Discussion
    • Conclusion
    • Notes
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Virtual house calls
  • Fixed drug eruption misdiagnosed as herpes simplex virus infection
Show more Case Report

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2026 by The College of Family Physicians of Canada

Powered by HighWire